Money20/20 Launches The Money Awards, the New Global Fintech Awards and Unveils Prestigious Jury President Line-Up
2.4.2025 14:10:00 CEST | Business Wire | Press Release
www.money2020.com, the world’s leading fintech show and the place where money does business, today announces the launch of The Money Awards, a premier global awards program recognizing transformative innovation across the financial technology ecosystem. Celebrating companies and leaders shaping the future of money, the money awardssets a new global benchmark for excellence in fintech.
Backed by a rigorous, merit-based judging process and a globally diverse panel of industry leaders, The Money Awards will recognize companies that are redefining industries, pushing the boundaries of technology, and setting new standards for product quality and innovation.
“The Money Awards are more than an awards program—they are a platform to showcase those leading the fintech revolution and will become the ultimate benchmark for innovation and impact in financial services,” said Scarlett Sieber, Money20/20’s Chief Strategy and Growth Officer. “Winning a Money award is a powerful catalyst for growth, investment, and global validation.”
The program features five awards: Startup, Banking, Payments, Partnerships & Strategic Alliance, and the Diamond Award. Each Award will be led by a distinguished Jury President, including Joanne Hannaford, CIO & CPO Corporate Bank of Deutsche Bank (Banking), Lynn Martin, President of NYSE Group (Diamond), Anthony Thomas, MD, FinTech at Delivery Hero (Partnerships & Strategic Alliance), Howard R. Fields, Chief Ethics & Compliance Officer at Mastercard (Payments), and Chetan Puttagunta, General Partner at Benchmark (Startup).
“I’m thrilled to serve as a Jury President for the inaugural Money20/20 Awards, recognizing the companies shaping the future of financial services,” said Lynn Martin, President of the New York Stock Exchange. “As the listing venue where big ideas come to life, the NYSE looks forward to celebrating the next generation of visionaries redefining the industry and setting the pace for global innovation.”
The Money Awards will be judged by an independent panel of globally respected leaders, with deep expertise and background in fintech, banking, payments, and technology. Jurors will evaluate submissions through a transparent and impartial process that includes online reviews followed by in-person deliberations at Money20/20 USA in October 2025.
“As a Jury President for the Money Awards, I’m honored to recognize the most prestigious global achievements in fintech,” said Joanne Hannaford, CIO & CPO Corporate Bank, Deutsche Bank. “A global fintech award not only celebrates outstanding accomplishments in our industry but also raises the bar for excellence, fosters innovation, and inspires the next generation of fintech leaders. I look forward to celebrating the groundbreaking companies and leaders redefining the future of financial technology.”
“I am honored and thrilled to be selected as a Jury President for the prestigious Money20/20 Payments Award,” said Howard R. Fields, Chief Ethics & Compliance Officer, Mastercard. “This award represents the pinnacle of innovation in the payments industry, recognizing groundbreaking ideas that shape the future of financial technology. I look forward to engaging with the brightest minds in the field and celebrating the transformative advancements that will define the next era of payments.”
The awards will culminate in the announcement of the inaugural Money Awards Trophy winners at Money20/20 USA, with further celebrations planned for Money20/20 Europe and Asia, ensuring global recognition for winning companies. Winners will receive a bespoke trophy and benefit from year-round visibility through Money20/20’s platforms, including exclusive speaking opportunities, media exposure, investor visibility, and networking at Money20/20 shows worldwide.
“I’m thrilled to serve as Jury President for this year’s Money20/20 Awards for Startups,” said Chetan Puttagunta. “Money20/20 has long been an important global platform for recognizing fintech innovation and propelling the industry forward. As an investor focused on early-stage startups, I'm particularly excited about the Startup Award—not only to elevate individual companies and entrepreneurs but also to create further collaboration in the ecosystem to drive the next generation of financial technology.”
Anthony Thomas, MD, FinTech at Delivery Hero, commented: “I'm excited to be a part of the Money20/20 Awards as Partnerships & Strategic Alliance Jury President. The fintech landscape thrives on collaboration, and I look forward to recognizing the companies and leaders who are forging impactful partnerships and shaping the future of financial services.”
Entries for jury applications are now open. For more information on categories, judging criteria, and how to enter, visit www.money2020.com/awards.
About Money20/20
Launched by industry insiders in 2012, Money20/20 has rapidly become the heartbeat of the global fintech ecosystem. Over the last decade, the most innovative, fast-moving ideas and companies have driven their growth on our platform. Mastercard, Wise, J.P. Morgan, SHIELD, Convera, Stripe, Google, VISA, Adyen, and more make transformational deals and raise their global profile with us. Money20/20 attracts leaders from the world’s greatest banks, payments companies, VC firms, regulators and media platforms: convening to cut industry-shaping deals, build world-changing partnerships and unlock future-defining opportunities in Bangkok (22-24 April 2025)in Amsterdam (3-5 June 2025), in Riyadh ( 15-17 September 2025), and in Las Vegas (26-29 October 2025). Money20/20 is where the world’s fintech leaders convene to grow their businesses. Money20/20 is part of Ascential plc. Follow Money20/20 on X and LinkedIn for show developments and updates. We’re Where Money Does Business. Follow Money20/20 on X for show developments and updates. You can also find us on LinkedIn at Money20/20.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402656688/en/
Contacts
TIna Loncaric
Global Head of PR
Money20/20
tina@money2020.com
M: +1 469 288 5556
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom